AERPIO PHARMACEUTICALS INC's ticker is ARPO and the CUSIP is 00810B105. A total of 25 filers reported holding AERPIO PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $31,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,193,946 | $3,531,000 | 0.07% |
| Alambic Investment Management, L.P. | 35,264 | $24,000 | 0.02% |
| Tekla Capital Management LLC | 257,554 | $175,000 | 0.01% |
| NEVILLE RODIE & SHAW INC | 100,000 | $68,000 | 0.01% |
| JOHNSON INVESTMENT COUNSEL INC | 320,536 | $218,000 | 0.00% |
| Ascent Wealth Partners, LLC | 10,000 | $7,000 | 0.00% |
| Truepoint, Inc. | 10,219 | $7,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 186,550 | $127,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 114,900 | $77,000 | 0.00% |